The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1b study of nivolumab in patients with autoimmune disorders and advanced malignancies (AIM-NIVO).
 
Ecaterina Elena Dumbrava
Consulting or Advisory Role - Bolt Biotherapeutics
 
Michael L. Dougan
Leadership - Neoleukin Therapeutics
Stock and Other Ownership Interests - Johnson & Johnson; Pfizer
Consulting or Advisory Role - Genentech/Roche; ORIC Pharmaceuticals; ORIC Pharmaceuticals; Partners Therapeutics; Tillotts Pharma
Research Funding - Novartis
 
Sarthak Gupta
No Relationships to Disclose
 
Laura Cappelli
Consulting or Advisory Role - Regeneron
Research Funding - Bristol-Myers Squibb
 
Tamiko R. Katsumoto
Consulting or Advisory Role - Genentech/Roche
Research Funding - Sanofi
 
Osama E. Rahma
Employment - Outcomes4me
Leadership - Outcomes4me
Honoraria - Alaunus Global; Clinical Care Options; Leerink; Merck; MI Bioresearch; PRMA Consulting
Consulting or Advisory Role - Alcimed; Bayer; Celgene; Defined Health; Five Prime Therapeutics; Genentech; Gfk; GlaxoSmithKline; Imvax; Leerink; Leerink; Maverick Therapeutics; Merck; PureTech; Putnam Associates; Sobi
Research Funding - Amgen (Inst); Merck
Patents, Royalties, Other Intellectual Property - PD-1/PD-L1 (Inst); Pending patent (DFCI 2386.010) (Inst)
Travel, Accommodations, Expenses - Clinical Care Options; Genentech; Merck; PRMA Consulting; PureTech
 
Jeane Painter
No Relationships to Disclose
 
Yinghong Wang
Consulting or Advisory Role - Tillotts Pharma
 
Maria E. Suarez-Almazor
Consulting or Advisory Role - Abbvie/Genentech; Agile Therapeutics; AMAG Pharmaceuticals; Endo Pharmaceuticals; Lilly; Pfizer
 
Pankti Reid
No Relationships to Disclose
 
Sarah F. Wesley
No Relationships to Disclose
 
David A Hafler
Consulting or Advisory Role - Sanofi
Research Funding - Bristol-Myers Squibb; Genentech; Sanofi
 
Clifton O. Bingham
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb
 
Blake M Warner
No Relationships to Disclose
 
Lorinda Chung
No Relationships to Disclose
 
Patrick Alexander Ott
Consulting or Advisory Role - Array BioPharma; Bristol-Myers Squibb; Celldex; CytomX Therapeutics; Genentech; Merck; Novartis; Pfizer
Research Funding - ARMO BioSciences (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); CytomX Therapeutics (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Merck (Inst); Neon Therapeutics (Inst); Pfizer (Inst)
Expert Testimony - Boehringer Ingelheim
 
Harriet M. Kluger
Consulting or Advisory Role - Array BioPharma; Bristol-Myers Squibb; Bristol-Myers Squibb; Celldex; Clinigen Group; ElevateBio; ElevateBio; Immunocore; Instil Bio; Iovance Biotherapeutics; Merck; Nektar; Shionogi
Research Funding - Apexigen (Inst); Bristol-Myers Squibb (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Apexigen
 
Arezou Khosroshahi
No Relationships to Disclose
 
Hussein Abdul-Hassan Tawbi
Consulting or Advisory Role - Array BioPharma; Bristol-Myers Squibb; Eisai; Genentech/Roche; Iovance Biotherapeutics; Merck; Novartis
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novartis (Inst)
 
Elad Sharon
No Relationships to Disclose